
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year |
Award Type![]() |
Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2006 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |
2006 | R44 | CA097569 | RFA-CA-06-005 | BRADY, ERIK D | MICROCOSM, INC. | ENHANCED CANCER MICROARRAY | Complete |
2008 | R44 | CA114126 | RFA-CA-07-039 | LIM, MARK | AMBERGEN, INC | ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE | Complete |
2006 | R44 | CA121155 | RFA-CA-06-005 | LU, PETER S. | ARBOR VITA CORPORATION | A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES | Complete |
2008 | R44 | CA120619 | RFA-CA-07-041 | LEE, PHILIP J | CELLASIC CORPORATION | MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
2008 | R44 | CA118785 | RFA-CA-06-006 | BROWN, DAVID M | AMBION DIAGNOSTICS, INC. | MIRNA PROFILING IN FIXED CANCER SAMPLES | Complete |
2008 | R44 | CA128858 | RFA-CA-07-008 | DOLINGER, DAVID LEE | IQUUM, INC. | RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS | Complete |
2006 | U43 | CA122745 | RFA-CA-06-006 | BALGLEY, BRIAN M. | CALIBRANT BIOSYSTEMS, INC. | BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES | Complete |